Chronic paroxysmal hericrania and hemicrania contnua. Parenteral indomethacin: The 'Indotest'

Fabio Antonaci, Juan A. Pareja, Ana B. Caminero, Ottar Sjaastad

Research output: Contribution to journalArticle

Abstract

The interval between indomethacin administration and clinical response may be clinically relevant in the assessment of chronic paroxysmal hemicrania continua and other unilateral headache disorders with they can be confounded. Eight patients with chronic paroxysmal hemicrania (6 women and 2 men) and 12 patients with hemicrania continua (8 women and 4 men) were entered into the study. The patients were given 50 mg of indomethacin intramuscularly (IM) on day 1 and some of them 100 mg IM on day 2 in an open fashion. The usual attack pattern was reestablished prior to the second test. The mean interval between attacks before the two injections (51 ± 18 minutes) in chronic paroxysmal hemicrania was significantly shorter than the mean after each of the two indomethacin injections (50 mg = 493 ± 251 minutes; 100 mg = 668 ± 211 minutes; P

Original languageEnglish
Pages (from-to)122-128
Number of pages7
JournalHeadache
Volume38
Issue number2
Publication statusPublished - 1998

Keywords

  • Algometry
  • Chronic paroxysmal hemicrania
  • Hemicrania continua
  • Indomethacin
  • Visual analog scale

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Fingerprint Dive into the research topics of 'Chronic paroxysmal hericrania and hemicrania contnua. Parenteral indomethacin: The 'Indotest''. Together they form a unique fingerprint.

  • Cite this

    Antonaci, F., Pareja, J. A., Caminero, A. B., & Sjaastad, O. (1998). Chronic paroxysmal hericrania and hemicrania contnua. Parenteral indomethacin: The 'Indotest'. Headache, 38(2), 122-128.